The current methods for molecular typing of HLA-DR alleles incur a substantial financial burden when performing large population studies. In the current study, we aimed to provide much less expensive typing approach with high predictability for DRB1 genotype. We have used a panel of three microsatellite markers in the class II region (D6S2666, D6S2665 and D6S2446) for genotyping and haplotype reconstruction in a total of 1687 Caucasian (1313 RA patients and 374 controls) and 1364 Korean individuals (744 RA patients and 620 controls), all of whom were previously genotyped for DRB1. We found that a total of 88.4 and 87.4% of all observed three-marker haplotypes could determine the DR type with a positive predictive value 40.8 with high sensitivity and specificity. There was a high degree of haplotype conservation when comparing Caucasian and Asian populations. Interestingly, we found that the majority of DRB1*09 and DRB1*10 alleles share a common three-marker haplotype in both Caucasian and Asian populations. This is unexpected, since these two alleles are found on very different haplotype families. In addition, these two alleles are both associated with rheumatoid arthritis, making the elucidation of these haplotype relationships potentially important for understanding disease susceptibility.
Introduction
The major histocompatibility complex (MHC) class II region encodes a-and b-chains of the DR, DQ and DP isotypes. These heterodimeric molecules are expressed on the cell surface and have a primary role in presenting peptide antigens to T cells. These loci are characterized by extensive polymorphism that is concentrated on the amino-acid residues that shape the peptide binding site and this allelic diversity has been associated with a wide variety of autoimmune, inflammatory and infectious diseases. 1, 2 The exact mechanism underlying these associations is for the most part unknown. 3, 4 Furthermore, the patterns of association are quite complex and despite the large literature, gaps in our knowledge remain. It is apparent that very large population studies continue to be a valuable means of understanding the diverse ways in which the MHC contributes to disease risk.
The current standard for typing class II alleles involve the use of sequence specific oligonucleotide probes (SSOP), also known as 'oligotyping'. 5 In the case of DR loci, this method involves PCR amplification of specific exonic regions (primarily exons 2 and 3) of DRb using multiple primer pairs and hybridizing the amplified material with sequence-specific probes. While quite precise, the method is labor intensive and expensive, with costs ranging up to hundreds of dollars per sample, depending on the resolution required. This makes large population studies a significant financial burden.
In the current report, we have used a panel of three microsatellites in the class II regions to provide a surrogate for traditional DRB1 oligotyping. This typing approach may be particularly useful for a 'first pass' at characterizing large population samples, at a cost of less than $1 per sample. Selected samples may then be subjected to more refined class II typing. In the course of these studies, we have demonstrated remarkable conservation of some microsatellite-DRB1 haplotypes, and many of these are conserved across Caucasian and Asian populations. Finally, an unexpectedly close relationship between DR9 and DR10 haplotypes has been observed. This finding may have relevance to understanding the MHC associations with RA, which have recently been shown to involve several distinct loci within the MHC.
Results

HLA-DRB1 typing and reconstruction of three-marker microsatellite haplotypes in Caucasian and Korean populations
A total of 1687 Caucasian and 1364 Korean DNA samples were used for the analysis. These samples included 1313 Caucasian patients with RA and 374 Caucasian controls; the Korean samples consisted of 744 RA patients and 620 controls. Supplementary Table 1 shows the DRB1 allele distribution in these populations, listed in order of frequency in controls. A total of 11 DR types and nine DRB1*04 subtypes were defined in Caucasians. In the Korean population, full DR typing was carried out for all allelic groups, leading to the definition of 36 DR subtypes. The frequencies of DRB1 in these populations are similar to previous reports, with enrichment of 'shared epitope' alleles in both RA patient groups.
In addition to DRB1 genotypes, three microsatellite markers in the class II region were analyzed, as shown in Figure 1 . These markers had primer pairs flanking bp positions (Build 35) 32505448 through 32505591 (D6S2666), 32511335 through 32511577 (D6S2665) and 32721575 through 32721726 (D6S2446). These microsatellite markers were found previously to be very polymorphic, 6, 7 and that was confirmed here: D6S2666, nine alleles; D6S2665, 10 alleles; and D6S2446, 16 alleles. A number (e.g. 6-7-3) was assigned for each allele at each marker, and haplotypes based only on these three markers were reconstructed using the PHASE program. 8, 9 
Reconstruction of four marker haplotypes at D6S2666-D6S2665-DRB1-D6S2446
We then used the PHASE program 8, 9 to reconstruct fourmarker haplotypes, including the DRB1 genotypic data along with the three microsatellite markers D6S2666, D6S2665 and D6S2446. A total of 173 and 149 fourmarker haplotypes were reconstructed in the Caucasian and Korean populations, respectively (Table 2 and 3) . Although a large number of haplotypes could be identified, many of these were rare (frequency o0.1%).
In the Caucasian population, a little over one third of the total haplotypes 62/173 (35.8%) had a frequency 40.1%, and these accounted for 95.2% of the haplotypes found in the Caucasian population. In the Korean population, a similar pattern was observed in that 74/149 (50%) of the haplotypes had frequencies of 40.1% and these accounted for the majority (96.7%) of the haplotypes in the Korean population.
The four-marker haplotypes shown in Tables 2 and 3 are grouped by DRB1 alleles or allelic families. Note that for each DRB1 group, only a few haplotypes tend to dominate. For example, the '4-8-DRB1*01-7' combination accounts for 85% of the DR1-associated haplotypes in Caucasians. DRB1*15/16, *03, *10, *11 and *12 show similar enrichment of a predominant haplotype within the group. Other DRB1 allelic families, such as DRB1*07 and DRB1*13, have several common haplotypes within the group. A similar pattern is observed in the haplotypes associated with the various Korean DRB1 alleles.
Note that within the DRB1*04 group of alleles, the '6-7-3' and 6-8-3' microsatellite haplotypes predominate, being enriched particularly in the DRB1*0401 and 0404 allelic subsets. This is consistent with the association of these three-marker haplotypes with RA, as shown in Table 1 . Similarly, the most strongly RA associated threemarker haplotypes in Koreans, '1-1-3' and '6-5-5' are predominantly found in association with DRB1*0405 and DRB1*0901, respectively. This is consistent with HLA associations with RA that have been previously reported in the Korean population.
Three microsatellite markers can used to predict the HLA-DRB1 type To determine whether particular haplotypes of three markers can be useful to predict DRB1 type or subtype, we obtained the sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratio for all haplotypes with greater than a 0.1% frequency. Tables 4 and 5 showed the data of those parameters for DRB1 types other than DRB1*04. Tables 6 and 7 shows these data for the DRB1*04 subtypes in each population. In addition to the most common haplotypes, we have included all the haplotypes with positive predictive values more than 0.8 in order to show the haplotypes that can be useful for DR typing in each population.
Despite high positive predictive values, many haplotypes within a DR group displayed low-sensitivity, because multiple haplotypes may be associated with a particular DRB1 allele. Thus, for example, as shown in Table 4 , DRB1*03 contains one major ('3-6-8') and two minor haplotypes in Caucasians. The minor microsatellite haplotypes ('6-4-5' and '6-4-6') have low-sensitivity but high-positive predictive value. However, if any of these three haplotypes are present, the sensitivity is high (0.927) and the PPV is close to 1 (0.997). Thus, in a practical sense, combinations of three-marker haplotypes can be used as good predictors of many of the common HLA-DRB1 allelic groups.
In one of our previous studies using the same three microsatellite markers, we reported that the particular haplotype '1-1-6' was nearly 100% accurate in predicting the haplotype 'DRB1*1501-DQB1*0602'. 7 Even though this three-marker haplotype was the major one predicting DRB1*15 in our current study, there were the other minor ones in both the Korean and Caucasian populations. This slight difference in accuracy between the two studies undoubtedly relates to the fact that several DRB1*1501 haplotypes exist in the population 10 other than the 'DRB1*1501-DQB1*0602' haplotype that is associated with systemic lupus and that was the focus of our previous analysis. 7 Within the DR4 group of alleles, typing specificity is less reliable as an indicator of DR4 subtype, particularly in Caucasians (Table 6 ). This is because many threemarker microsatellite haplotypes are in LD with several of the DR4 subtypes. For example, the '6-7-3' haplotype is commonly found in association with DRB1*0401, 0403 and 0404 alleles. At the same time, while the '6-8-3' haplotype is quite specific (0.995) and predictive (0.945) for DRB1*0401, it is not very sensitive (0.28) as it is only found on a minority of 0401 haplotypes. The situation in Korean population is somewhat less complex, in part, because the DRB1*0405 allele is predominant in this population, as shown in Table 7 . Thus, as shown in Table 7 , the '1-1-3' haplotypes is highly specific (0.99) and quite sensitive (0.88) for the *0405 allele, with a PPV ¼ 0.95.
A striking feature of these data is that the DRB1*09 and DRB1*10 alleles were not well delineated using this three-marker haplotype method. This is because a large majority of DRB1*09 and almost all DRB1*10 alleles contained the haplotype '6-5-5' three-marker microsatellite haplotype. This was true in both Korean and Caucasian populations. As discussed below, this haplotype similarity is unexpected, since DR9 and DR10 belong to quite distinct haplotype families.
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Discussion
We have established a microsatellite haplotyping method that can serve as a surrogate for 'broad level' DRB1 genotyping with very good sensitivity and specificity for most of the major DRB1 allelic groups. By using three microsatellite markers, we found that a total of 88.4 and 87.4% of all observed three-marker haplotypes could determine the DR type with a positive predictive value 40.8 in Caucasian and Korean populations, respectively. This method will be especially useful for DR screening of large populations, since it can be carried out at a fraction of the cost of traditional DRB1 oligotyping. For studies that require more definitive DRB1 subtyping, investigators can select samples that carry the haplotypes common to particular allelic groups, and focus the more expensive oligotyping on those samples that require precise genetic definition.
As HLA-DR alleles are strong risk factors for many autoimmune, infectious and inflammatory disorders, 1,2 it is often necessary to take this into account when studying both the genetic and environmental contributions to disease in populations. This is usually done in the context of either case-control or longitudinal cohort studies. It is our hope that this new approach to HLA-DR typing can make such studies more affordable to a wider array of research laboratories by dramatically reducing the costs of obtaining basic information on DRB1 genotypes. The future analysis and addition of SNPs in the region, in combination with these microsatellite markers, will undoubtedly improve the accuracy of this approach.
Beyond the practical implications, our studies have yielded insights into class II haplotype relationships with potential implications for understanding the MHC associations with rheumatoid arthritis. In general, we found that there is a high degree of haplotype conservation when comparing Caucasian and Asian populations. Some of these shared haplotypes are predominant in both populations, such as the '4-8-DRB1*01-7' haplotype and the '1-1-DRB1*1501 (DR2)-6' haplotype (see Tables 4  and 5 ). DR4-related haplotypes also commonly share the three-marker microsatellite combination '6-7-3' in both populations, although the '1-1-DRB1*0405-3' haplotype predominates in the Korean population. This commonality of haplotypes across the major ancestral groups is consistent with the ancient origin of these haplotype families. [15] [16] [17] We also observed that certain microsatellites exhibited multiple repeat differences within a haplotype group. For example, multiple alleles of the D6S2446 microsatellite are found on DR*07 haploytpes, involving GT repeats between 13 and 16, giving rise to multiple three-marker haplotypes in this group (e.g. 1113, 1114, 1115, 1116). This may relate to the decreased stability of longer repeats that has been described, 18 and therefore may not reflect a true excess of overall genetic heterogeneity within the DR7 haplotype family.
However, the three-marker haplotype relationship between DR9 and DR10 alleles is unexpected. The majority of DRB1*09 and DRB1*10 alleles share a common three-marker microsatellite combination, '6-5-5' in both Caucasian and Asian populations. This might suggest that DR9 and DR10 belong to a common haplotype family. However, it is quite clear that this is not the case. Overall, the DR subregion has been characterized by missing or alternative arrangements of HLA-DRB genes and pseudogenes that form five major haplotype families, broadly designated as the DR1, DR8, DR51, DR52 and DR53 haplotype family groups.
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DRB1*09 is clearly a member of the DR53 family containing two functional DRB genes (DRB1 and DRB4) and several pseudogenes, such as cDRB7, cDRB8, and cDRB9. On the other hand, DRB1*10 is a member of the DR1 family group that has only one functional DRB1 locus and two pseudogenes cDRB6 and cDRB9 DR9 and DR10 have also been shown to have different patterns of linkage disequilibrium with the DQ region. 10, [12] [13] [14] We have also previously proposed, based on the sequencing of 3'-UT region of DRB1 alleles, that DRB1*10 allele is quite distant evolutionally from DR53 family (DRB1*04, *07 and *09) but more closely related to the DR1/DR2 haplotype family. 11 For this reason, the local haplotype similarity of '6-5-5' within the DR region between DR9 and DR10 cannot be due to ancient family relationships.
This raises the possibility that one or more gene conversion or recombination events may have occurred between ancestral haplotypes in these two haplotype families.
As only three microsatellites have been run in this study, we cannot assess the extent of the similarity between DR9 and DR10 in the class II region. D6S2666 and D6S2665 are located between BTNL2 in the central MHC and HLA-DRA. An examination of our previous microsatellite data in Caucasians suggests that the telomeric extent of this haplotype similarity may extend a few hundred thousand base pairs into the central MHC (data not shown). 6 As the D6S2446 marker is centromeric to the HLA-DQA gene, this region may not in fact be part of the shared region between the DR9 and DR10 haplotypes. However, we will need to carry out a dense SNP map of these haplotypes in order to define this region of similarity more precisely. These results are intriguing because the association of RA with DRB1*0901 in the Korean populations carries especially high risk when present as a compound heterozygote with DRB1*0405. 19 This is reminiscent of the high risk of DRB1*0401/0404 compound heterozygotes in Caucasians. 20, 21 Whether DR10 confers similar effects has not been previously addressed, since this allele is so uncommon in Asian populations. 14, 19 However, a preliminary analysis of the currently available data suggest that the DRB1*0405/1001 genotype also confers very high risk for RA in the Korean population with OR ¼ 13.3, 95% CI 1.79-99.2 (22/1149 in cases, 1/698 in controls) (Table 8) . Clearly, these data need to be replicated. However, they suggest that the haplotype segment that is shared between DR9 and DR10 may have common functional effects.
Both the DR9 and DR10 associations with RA have been commonly ascribed to the similarity of their DRB1 sequences to the 'shared epitope' alleles. 22 These RA associated alleles carry the sequence Q-K/R-R-A-A at positions 70-74 of the DRB1 chain. DRB1*10 has the 70 R-R-R-A-A 74 motif in this region, and DRB1*09 encodes a 70 R-R-R-A-E 74 motif. Notably, the glutamic acid (E) in position 74 of DRB1*09 is also found in DRB1*0403, an allele that is not associated with RA. 20 While the triple arginine sequence at 70-72 may confer functional similarity to the other shared epitope alleles, it is tempting to speculate that additional allelic variation on DR9 and DR10 haplotypes may at least in part account for the patterns of association with RA. Addressing this hypothesis will require a thorough sequence analysis and comparison of these two haplotypes, as well as more focused population association studies to address their possible interactions with other DRB1 risk alleles.
Materials and methods
Study populations
Caucasians (n ¼ 1698) in the present study were 1322 RA patients, who were drawn from the North American Rheumatoid Arthritis Consortium (NARAC) collection 23 and 376 healthy controls in the New York Cancer Project (NYCP) who were cancer-free at the time of enrollment. 24 Korean populations (n ¼ 1394) consisted of 746 RA patients who were recruited consecutively from the outpatient clinic of The Hospital for Rheumatic Diseases, Hanyang University, Seoul, South Korea and 648 healthy volunteers who were ethnically matched and enrolled from among the staff at the same hospital (nurses, paramedical personnel and laboratory workers). All RA patients in both groups met the American College of Rheumatology 1987 classification criteria for RA. 25 Written informed consent was obtained from all participants.
Laboratory procedures
Caucasian RA and control participants were HLA-DRB typed using the SSOP low-resolution method. All individuals with DRB1*04 were subsequently tested using a medium resolution panel, providing subtype results. In all Korean participants, typing for HLA-DRB1 was performed by polymerase chain reaction sequencebased typing (PCR-SBT) method using the reference protocol of the Twelfth International Histocompatibility Workshop. 5 Three microsatellite markers nearby HLA-DRB1, which were chosen from the 54 markers distributed throughout the HLA complex as described elsewhere, 6, 7 were D6S2666, D6S2665 and D6S2446. The exact marker locations were determined from University of California, Santa Cruz, Genome Bioinformatics Web site, the Web site of the Sanger Institute, and the Web site of dbMHC microsatellite markers.
Fluorescent genotyping was performed in 96-well plates using three fluorescently labeled oligonucleotides amplified in a single multiplex reaction. PCR (40 cycles) was performed on a MJ Research tetrad (10 ml reactions: 2 ng genomic DNA, 2.5 nM MgCl2, 0.2 mM dNTPs (Amersham Biosciences, Piscataway, NJ, USA) 0.242 mmol of D6S2666 5 0 and 3 0 primers, 0.161 mmol of D6S2665 5 0 and 3 0 primers, and 0.081 mmol of D6S2446 5 0 and 3 0 primers (Integrated DNA Technologies, Coralville, IA, USA), 0.04 U of Amplitaq Gold DNA Polymerase (Perkin-Elmer, Shelton, CT, USA) in 10 Â PCR Buffer II (Perkin-Elmer, Shelton, CT, USA). Amplified products were electrophoresed with 500 ROXt size standard (Applied Biosystems, Foster City, CA, USA) through Performance Optimized Polymer-4 (ABI) for 35 min at 15 Volts using a 3700 DNA Analyzer (Applied Biosystems, Foster City, CA, USA). Fragment sizes were calculated using Genescan v3.6 analysis and analyzed using Genotyper v3.6NT software (ABI). Each genotype was read independently by two individuals, to ensure accutate calling of alleles. There were 11 samples and 30 samples in which reaction of all three markers failed, resulting in a total of 1687 (1313 RA patients and 374 controls) and 1364 (744 RA patients and 620 controls) samples for haplotype reconstruction in Caucasians and Koreans, respectively.
Data analysis
To match the particular three-marker haplotype and DRB1, haplotype reconstruction was performed for four markers including three markers and DRB1 allele using PHASE v2.1.1, 8, 9 which employs a Markov Chain Monte Carlo algorithm that is based on the coalescent model. The reconstructed haplotypes were analyzed for associations with the DR types using Fisher's Exact Probability Test. The adjusted logit estimate of the OR and the corresponding CI were computed by Woolf modification. All analyses were conducted using the SAS software package, version 9.1 (SAS Institute, Cary, NC, USA). Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratio were then calculated in order to evaluate the relationship between the HLA typing and the haplotypes that were a frequency 40.1% within each population and were found to be significantly associated with a particular DR type. This analysis was performed in patients with RA and controls with HLA typing using high-resolutional method in Korean populations. The number of these data is larger than the number of Korean subjects using three-marker microsatellite method in this study. NA, not available.
